Xenon Pharmaceuticals Inc.
XENE | NASDAQ
$38.29
-$0.70 (-1.80%)
Sep 22, 2026, 12:46 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -10.28 | -13.02 | -16.87 | -19.14 | -17.65 | -18.53 |
PEG Ratio | -0.23 | -1.27 | -0.52 | -1.17 | -0.16 | 0.40 |
PS Ratio | 473.62 | n/a | n/a | 253.04 | 73.92 | 16.52 |
PB Ratio | 6.11 | 4.04 | 3.32 | 3.31 | 2.48 | 3.10 |
P/FCF Ratio | -12.69 | -16.55 | -20.41 | -23.56 | -19.05 | -10.47 |
P/OCF Ratio | -12.73 | -16.83 | -21.20 | -24.25 | -19.61 | -11.04 |
OCF/S Ratio | -3.72K | n/a | n/a | -1.04K | -376.97 | -149.61 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
Quick Ratio | 13.42 | 17.85 | 23.65 | 26.44 | 39.03 | 12.30 |
Current Ratio | 13.42 | 17.85 | 23.65 | 26.44 | 39.03 | 12.30 |
Asset Turnover | 0.01 | n/a | n/a | 0.01 | 0.03 | 0.17 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -64.67 |
Return on Equity | -59.46% | -31.04% | -19.66% | -17.38% | -14.34% | -16.83% |
Return on Assets | -35.24% | -29.36% | -18.90% | -16.62% | -13.79% | -15.24% |
Return on Invested Capital | -39.63% | -35.93% | -22.76% | -17.64% | -14.15% | -17.76% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 66.09% | n/a | n/a | 100% | 100% | 100% |
Net Profit Margin | -4.61K% | n/a | n/a | -1.33K% | -427.85% | -89.65% |
Pretax Profit Margin | -4.6K% | n/a | n/a | -1.33K% | -427.88% | -90.45% |
Operating Profit Margin | -4.97K% | n/a | n/a | -1.37K% | -428.45% | -97.31% |
FCF Margin | -3.73K% | n/a | n/a | -1.07K% | -388.09% | -157.81% |
EBITDA Margin | -4.56K% | n/a | n/a | -1.35K% | -423.53% | -86.94% |
Add to Watchlist
Select watchlists to add or remove XENE